Inventor profile of:

Sven Hellberg

City:

Sodertalje

Country:

Sweden

Published Applications:

29

Last publication date:

2011-02-03

Top Assignees for applications by Sven Hellberg

The entities that hold a legal rights for patent applications filed by inventor Hellberg Sven:

Recent patent applications by Hellberg Sven

Sven Hellberg from Sodertalje, SE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2011-02-03
US20110028489A1
Chemistry; metallurgy

Pyrimidine Derivatives and Their Use for Treating Bone-Related Disorders

#2 | 2010-04-01
US20100081660A1
Chemistry; metallurgy

Novel Compounds Having Selective Inhibiting Effect at GSK3

#3 | 2010-03-25
US20100075989A1
Chemistry; metallurgy

Novel Compounds Having Selective Inhibiting Effect at GSK3

#4 | 2009-12-17
US20090312322A1
Chemistry; metallurgy

Use of Oxindole Derivatives in the Treatment of Dementia Related Diseases, Alzheimer's Disease and Conditions Associated with Glycogen Synthase Kinase-3

#5 | 2009-09-17
US20090233943A9
Chemistry; metallurgy

NEW COMPOUNDS 835

#6 | 2009-09-17
US20090233930A9
Chemistry; metallurgy

Novel 2-Amino-Imidazole-4-One Compounds and Their Use in the Manufacture of a Medicament to Be Used in the Treatment of Cognitive Impairment, Alzheimer's Disease, Neurodegeneration and Dementia

#7 | 2009-06-11
US20090149460A1
Chemistry; metallurgy

New Compounds

#8 | 2009-04-23
US20090105252A1
Chemistry; metallurgy

Pyrimidine Derivatives and Their Use in Therapy as well as the Use of Pyrimidine Derivatives in the Manufacture of a Medicament for Prevention and/or Treatment of Alzheimer's Disease

#9 | 2009-04-16
US20090099217A1
Chemistry; metallurgy

2-Aminopyrimidin-4-Ones And Their Use For Treating Or Preventing Alpha Beta-Related Pathologies

#10 | 2009-01-22
US20090023762A1
Chemistry; metallurgy

Substituted 2-Aminopyrimidine-4-Ones, Their Pharmaceutical Compositions And Their Use In The Treatment And/Or Prevention Of Ab-Related Pathologies

#11 | 2009-01-15
US20090018130A1
Chemistry; metallurgy

Derivatives of 5-Aryl-1H-Pyrrolo [2, 3B] Pyridine-3-Carboxamide or 5-Aryl-1H-Pyrrolo [2, 3B] Pyridine-3-Carboxylic Acid

#12 | 2008-11-27
US20080293718A1
Chemistry; metallurgy

Novel 2-Amino-Imidazole-4-One Compounds and Their Use in the Manufacture of a Medicament to Be Used in the Treatment of Cognitive Impairment, Alzheimer's Disease, Neurodegeneration and Dementia

#13 | 2008-11-20
US20080287460A1
Chemistry; metallurgy

NEW COMPOUNDS 835

#14 | 2008-11-06
US20080275041A1
Chemistry; metallurgy

3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (GSK-3)

#15 | 2008-09-04
US20080214560A1
Chemistry; metallurgy

Use of Pyrimidine Derivatives in the Manufacture of a Medicament for Prevention and/or Treatment of Alzheimer's Disease

#16 | 2008-03-18
US10468604
-

Pyrimidine compounds

#17 | 2006-08-31
US20060194854A1
Chemistry; metallurgy

New 2-substituted - 1,3-thiazole compounds

#18 | 2006-08-03
US20060173014A1
Chemistry; metallurgy

Compounds having selective inhibiting effect at GSK3

#19 | 2006-07-18
US10468605
-

2-arylamino-pyrimidines for the treatment of GSK3-related disorders

#20 | 2006-06-01
US20060116385A1
Chemistry; metallurgy

Compounds having selective inhibiting effect at GSK3

#21 | 2006-06-01
US20060116362A1
Chemistry; metallurgy

Compounds having selective inhibiting effect at GSK3

#22 | 2006-03-09
US20060052396A1
Chemistry; metallurgy

Arylamines for the treatment of conditions associated with gsk-3

#23 | 2005-10-06
US20050222181A1
Chemistry; metallurgy

Compounds in the treatment of dementia related diseases, Alzheimer's Disease and conditions associated with glycogen synthase kinase-3

#24 | 2005-07-14
US20050153987A1
Chemistry; metallurgy

3-Heterocyclyl-indole inhibitors of glycogen synthase kinase-3

#25 | 2005-06-02
US20050119321A1
Chemistry; metallurgy

2-substituted-1,3-thiazole compounds

#26 | 2005-04-07
US20050075351A1
Human necessities

Use

#27 | 2005-03-31
US20050070559A1
Chemistry; metallurgy

Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3

#28 | 2005-03-24
US20050065170A1
Chemistry; metallurgy

Compounds for the treatment of dementia related diseases

#29 | 2005-03-10
US20050054698A1
Chemistry; metallurgy

4-(4Methoxybenzyl)-n′-(5-nitro1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3 (gsk3)

InventorID:

3339623 āŽ˜